Nailfold capillaroscopic findings in primary Sjögren’s syndrome with and without Raynaud’s phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies

被引:0
作者
Hèctor Corominas
Vera Ortiz-Santamaría
Iván Castellví
Mireia Moreno
Rosa Morlà
Teresa Clavaguera
Alba Erra
Silvia Martínez-Pardo
Sergi Ordóñez
Pilar Santo
Patricia Reyner
Maria José González
Oriol Codina
Mario Saul Gelman
Xavier Juanola-Roura
Alex Olivé
Vicenç Torrente-Segarra
机构
[1] Consorci Sanitari Integral (CSI),Service of Rheumatology, Hospital de Sant Joan Despí Moisés Broggi
[2] Hospital de Granollers,Hospital General Hospitalet
[3] Universitat Autònoma de Barcelona,Service of Rheumatology
[4] Hospital Corporació Parc Taulí,Service of Rheumatology, Hospital Universitari de Sant Pau
[5] Hospital del Vendrell,Service of Rheumatology
[6] Hospital de Palamós,Service of Rheumatology
[7] Hospital Sant Rafael,Service of Rheumatology
[8] Hospital Universitari Mútua de Terrassa,Service of Rheumatology
[9] Hospital Arnau de Vilanova,Service of Rheumatology
[10] Hospital Universitari de Bellvitge,Service of Rheumatology
[11] Hospital de Santa Caterina,Service of Rheumatology
[12] Hospital Universitari Quirón Dexeus,Service of Rheumatology
[13] Hospital de Figueres,Service of Rheumatology
[14] Fundació Althaia Hospital de Manresa,Service of Rheumatology
[15] Hospital Universitari Germans Trias,Service of Rheumatology
来源
Rheumatology International | 2016年 / 36卷
关键词
Antibodies, antinuclear; Connective tissue diseases; Microscopic angioscopy; Raynaud’s disease; Sjögren’s syndrome; Systemic sclerosis;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of this study was to assess nailfold capillaroscopic (NC) findings in patients with primary Sjögren’s syndrome (PSS) with and without Raynaud’s phenomenon (RP) as well as in the presence of positive anti-SSA/Ro and anti-SSB/La antibodies. Videocapillaroscopy was performed in 150 patients with PSS. Data collected included demographics, presence of RP, PSS symptoms, antinuclear antibodies, rheumatoid factor, anti-Ro, anti-La, anti-CCP, salivary scintigraphy, labial biopsy, and NC findings. RP was present in 32 % of PSS, keratoconjunctivitis sicca in 91 %, oral xerosis in 93 %, and skin or genital xerosis in 53 %. In patients with positive anti-SSA/Ro (75 %) and positive anti-SSB/La (40 %), NC showed normal findings in 53 % of cases and non-specific in 36 %. In patients with PSS, NC was normal in 51 % of cases and non-specific in 34 %. Scleroderma pattern was found in 14 patients. RP associated with PSS had non-specific capillaroscopy in 40 % of cases (p = 0.1). Pericapillary haemorrhages (p = 0.06) and capillary thrombosis (p = 0.2) were not increased, but more dilated capillaries were detected in 48 % of cases. Patients with positive anti-Ro and/or anti-La have not a distinct NC profile. Patients with RP associated with PSS had more dilated capillaries, but neither pericapillary haemorrhages nor capillary thrombosis was observed.
引用
收藏
页码:365 / 369
页数:4
相关论文
共 3 条
  • [1] Nailfold capillaroscopic findings in primary Sjogren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies
    Corominas, Hector
    Ortiz-Santamaria, Vera
    Castellvi, Ivan
    Moreno, Mireia
    Morla, Rosa
    Clavaguera, Teresa
    Erra, Alba
    Martinez-Pardo, Silvia
    Ordonez, Sergi
    Santo, Pilar
    Reyner, Patricia
    Jose Gonzalez, Maria
    Codina, Oriol
    Saul Gelman, Mario
    Juanola-Roura, Xavier
    Olive, Alex
    Torrente-Segarra, Vicenc
    RHEUMATOLOGY INTERNATIONAL, 2016, 36 (03) : 365 - 369
  • [2] Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block
    Costedoat-Chalumeau, N
    Georgin-Lavialle, S
    Amoura, Z
    Piette, JC
    LUPUS, 2005, 14 (09) : 660 - 664
  • [3] CAPILLAROSCOPIC FINDINGS IN PATIENTS WITH SJOGREN'S SYNDROME, SYSTEMIC SCLEROSIS, AND PRIMARY RAYNAUD'S PHENOMENON IN A HIGH-COMPLEXITY CENTER IN MEDELLIN, COLOMBIA 2016-2022
    Hoyos-Patino, S.
    Arango-Martinez, A.
    Rodriguez Padilla, L. M.
    Chavarriaga Restrepo, A.
    Velasquez-Franco, C. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1630 - 1630